Signup/Login
If you want to receive notifications of upcoming IPOs, you need to simply sign up or sign in with social networks.
Signup/Login
Can you determine which companies are good and which ones - the trash?
Free Pro-version
IPO Filter
Monitor
IPO today
Upcoming IPO
Biofrontera (BFRI)
Marpai (MRAI)
Cingulate, Inc. (CING)
Stronghold Digital Mining, Inc. (SDIG)
Enfusion, Inc. (ENFN)
Portillos Inc. (PTLO)
Winc, Inc. (BEV)
The Vita Coco Company, Inc. (COCO)
P10, Inc. (PX)
Ventyx Biosciences, Inc. (VTYX)
Winc, Inc. (WBEV)
Runway Growth Finance Corp (RWAY)
Aris Water Solutions, Inc. (ARIS)
Minerva Surgical, Inc (UTRS)
Xilio Therapeutics, Inc. (XLO)
Informatica Inc. (INFA)
Arteris, Inc. (AIP)
Priced IPO
Mink Therapeutics, Inc. (INKT)
Paragon 28, Inc. (FNA)
Ihs Holding Limited (IHS)
Gitlab Inc. (GTLB)
Lucid Diagnostics, Inc. (LUCD)
Healthcare Triangle (HCTI)
AvidXchange (AVDX)
Cognition Therapeutics, Inc. (CGTX)
Isoplexis Corporation (ISO)
Pyxis Oncology, Inc. (PYXS)
Life Time Group Holdings, Inc. (LTH)
Theseus Pharmaceuticals, Inc. (THRX)
Tricon Residential (TCN)
Volcon (VLCN)
Nuvei (NVEI)
Tdcx, Inc. (TDCX)
First Watch Restaurant Group, Inc. (FWRG)
Exscientia Limited (EXAI)
Warby Parker (WRBY)
Olaplex Holdings Inc. (OLPX)
More companies

SEQLL (SQL)

Sector - Healthcare

Price chart

-18.35%
Return from IPO

Company News

IPO Profile

About company

Company Logo
They are a life sciences instrumentation and services company focused on providing their tSMS™ technology to the scientific and medical community in order to accelerate the understanding of the molecular mechanisms of disease and fundamental biological processes. They have developed and offer a unique, proprietary sequencing technology platform in the multi-billion-dollar NGS market, ideally suited for emerging applications in the research and development of precision medicine and epigenetic investigations. Their technology advantage provides a simple method of quantifying DNA and RNA molecules at single molecule resolution, eliminating bias from PCR amplification or other preparation steps required by other technologies. Data produced by their tSMS platform generate accurate, reproducible molecular profiles, often revealing previously unknown characteristics and providing new insights into the biology being researched. Leveraging their expertise with the tSMS technology platform, they aim to provide the scientific and medical communities with tools for development of diagnostic applications that could lead to improved outcomes for patients with chronic and fatal diseases.
Industry
Laboratory Analytical Instruments
CEO CFO
Daniel Jones John W. Kennedy
Employees Founded
8 2013

Contacts

Address: 317 New Boston Street, Suite 210 Woburn, Massachusetts 01801

Telephone: (781) 460-6016

Web page: http://www.seqll.com

IPO information

First Trade Date 8/27/2021
Status Priced
Exchange NASDAQ
Lockup Period Expiration .Pro
Quiet Period Expiration .Pro
Old Price Range
-
Share prices ($)

Shares & Volumes

Shares Initial (MM) 1.4
Shares Revised (MM) 3.1
Expected offer amount (MM) $8
Realized offer amount(MM) $13.18

Financial Data (last reporting year)

Market Cap (MM) $52.01
Revenues (MM) $0.33
Net Income (Loss) (MM) $-2.01

Voting

What do you think will happen with the SQL share price after the next 3-6 months? 🔥 (+ 10% or more, flat (+ -10%), -10% or less)

Number of votes: img
The lead left underwriter: WallachBeth Capital, LLC

IPOs led by the firm .Pro
Profitability of conducted IPOs  ?  .Pro
1st day change  ?  .Pro
Change for the first 3 months  ?  .Pro
Underwriters
WallachBeth Capital, LLC
CO-Managers
-

Sector: Healthcare

Tweets about $SQL

Tweets volume:

RT volume:

Timeframe:

Google Trends Stats